FDA Drug recall D-0377-2022
SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24
- FDA Drug
- Class I
- terminated
- Published 2022-01-26
On 2022-01-26 the FDA classified a Class I recall of SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24 by Lohxa, citing microbial Contamination of Non-Sterile Product.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0377-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2021-12-21 |
| Published | 2022-01-26 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lohxa |
| Distribution | US |
Product
SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24.
Reason
Microbial Contamination of Non-Sterile Product
Identifiers
| code_info | Lot #: AM1115S, Exp. Date 01/2023 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0377-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.